| 000 | 06858nam a22004573i 4500 | ||
|---|---|---|---|
| 001 | EBC3018321 | ||
| 003 | MiAaPQ | ||
| 005 | 20240729124057.0 | ||
| 006 | m o d | | ||
| 007 | cr cnu|||||||| | ||
| 008 | 240724s2009 xx o ||||0 eng d | ||
| 020 |
_a9781607410959 _q(electronic bk.) |
||
| 020 | _z9781606926192 | ||
| 035 | _a(MiAaPQ)EBC3018321 | ||
| 035 | _a(Au-PeEL)EBL3018321 | ||
| 035 | _a(CaPaEBR)ebr10660182 | ||
| 035 | _a(OCoLC)923658145 | ||
| 040 |
_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 | _aQP572.A54 -- A543 2009eb | |
| 082 | 0 | _a572/.744 | |
| 100 | 1 | _aDeBrue, Anne N. | |
| 245 | 1 | 0 | _aAngiotensin Converting Enzyme Inhibitors. |
| 250 | _a1st ed. | ||
| 264 | 1 |
_aNew York : _bNova Science Publishers, Incorporated, _c2009. |
|
| 264 | 4 | _c©2009. | |
| 300 | _a1 online resource (252 pages) | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 505 | 0 | _aIntro -- ANGIOTENSIN CONVERTING ENZYME INHIBITORS -- Contents -- Preface -- Angiotensin Converting Enzyme Inhibitors -- Abstract -- Introduction - The Components of the Renin Angiotensin Aldosterone System (RAAS) -- Structure and Structure Activity Relationships of the ACEIs -- Clinical Indications and Uses of the ACEIs -- Adverse Effects of the ACE Inhibitors with Special Reference to Worsening Renal Failure in CKD Patients -- Conclusion/Post-Script -- References -- Adverse Effects of Angiotensin-Converting Enzyme Inhibitor: A Review of the Literature -- Abstract -- Introduction -- ACEI-Associated Cough -- Hypersensitivity Reaction During Hemodialysis -- ACEI-Associated Anemia -- ACEI-Induced Lung Disease -- References -- Plant-Derived Substances as ACE Inhibitors - Biosynthesis-Activity Relationship of Flavonoids, Terpenes and Sterols on Angiotensin-Converting Enzyme Activity in Human Endothelial Cells -- Abstract -- Introduction -- Aim of this Study -- Material and Methods -- Results (Table 1) -- Conclusion -- Acknowledgments -- References -- The Proper Use of Angiotensin-Converting Enzyme Inhibitors in Patients with Chronic Kidney Disease -- Abstract -- Introduction -- Effects of ACE inhibitors on Renal and Glomerular Hemodynamics -- Effects of ACE Inhibitors on Proteinuria -- Increasing the Doses of ACE Inhibitors or the Addition of ARB? -- Excretion and Plasma Concentration of ACE Inhibitors in Patients with Chronic Renal Failure -- Upper Limit of Serum Creatinine to Add on ACE Inhibitor -- Long-Term Renoprotective Effects and Escape Phenomenon by Use of ACE Inhibitors -- Side Effects of ACE Inhibitors in Patients with Chronic Renal Failure -- Influence of Gene Polymorphisms on Renoprotective Effects of ACE Inhibitors -- Compliance of Taking ACE Inhibitors -- Additional Therapy with ACE Inhibitors. | |
| 505 | 8 | _aClinical Approach for Proper Use of ACE Inhibitors -- Summary -- Patients and Methods -- Acknowledgements -- References -- Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function -- Abstract -- Abbreviation: -- * Median follow-up -- Potential Mechanisms of ACEI Beneficial Activity in Patients with CAD -- Clinical Uses of ACEI in Cardiovascular Diseases -- Randomized Clinical Trials Examining the Use of ACEI in Patients with CAD and Preserved LV Systolic Function -- Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme (IMAGINE) Trial -- Meta Analysis of the Effects of ACEI in Patients with Normal LV Function and CAD -- Putting it Together -- References -- Dual Blockade of the Renin-Angiotensin System: Angiotensin Converting Enzyme Inhibition, Angiotensin Receptor Blockade and Renin Inhibition -- Abstract -- Introduction -- Differences in the Mechanisms of Action of RAS Blockers -- Rationale of Dual RAS Blockade -- Dual RAS Blockade and Blood Pressure -- Dual RAS Blockade and Target Organ Damage -- Dual RAS Blockade and Cardiovascular-Renal Outcome -- Safety of Long-Term Dual RAS Blockade -- Conclusion -- References -- Angiotensin-Converting Enzyme Inhibitors in Patients with Bilateral Atherosclerotic Renal Artery Stenosis -- Abstract -- Introduction -- Definition -- Pathophysiology -- Clinical Manifestations -- Diagnosis -- Therapeutic Approach -- Cardiovascular Risk Associated with Aras -- Angiotensin Inhibitors in Animal Studies of ARAS -- Angiotensin Inhibitors in Human Studies of ARAS -- Acute Renal Failure and ACE Inhibitors -- Heterogeneity of Patient Subtypes -- Future Perspectives -- Conclusion -- References -- Angiotensin Converting Enzyme Inhibitors in Renal Disease -- Introduction. | |
| 505 | 8 | _aThe Experimental Basis of Ace Inhibitors Nephroprotection -- Renin-Angiotensin System Actions Inside the Kidney -- Proposed Mechanisms for Renoprotection -- Clinical Use of Ace Inhibitors in Renal Disease -- Beyond Blood Pressure Control? -- Meta-Analyses on Renoprotective Effects of Ace Inhibitors -- Combination of Ace Inhibitors and ARBS in Renal Disease -- Ace Inhibitors or ARBS for Renal Disease?. -- Safe Use in Patients with Renal Failure -- References -- The Kallikrein- Kinin Pathways in Mediating the Hypotensive Action of Angiotensin Converting Enzyme (ACE) Inhibitors -- Abstract -- Introduction -- Kallikrein-Kinin System -- Kinin Receptors -- Kallikrein-Kinin and Renin Angiotensin Systems Interaction -- Kallikrein-Kinin System During Hypertension -- Antihypertensive Effects of Kininase II Inhibitors (ACEIs) -- Kinin Receptors Antagonists and Angiotensin Converting Enzyme (Kininase Ii) Inhibitors -- Summary -- References -- Angiotension Converting Enzyme Inhibitors: Improving Utilization and Adherence -- Abstract -- Introduction -- Magnitude of the Problem -- Barriers to Use -- Improving Adherence: Solutions -- Conclusion -- References -- Angiotensin Blockade in Pediatric Chronic Kidney Disease -- Abstract -- Introduction -- Renoprotection from Angiotensin Blockade -- Pediatric Studies on Angiotensin Blockade -- Effect On Proteinuria -- Effect on BP -- Progression of CKD -- Safety Considerations -- Conclusion -- References -- Index. | |
| 588 | _aDescription based on publisher supplied metadata and other sources. | ||
| 590 | _aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. | ||
| 650 | 0 | _aAngiotensin converting enzyme -- Inhibitors. | |
| 650 | 0 | _aKidneys -- Diseases -- Chemotherapy. | |
| 655 | 4 | _aElectronic books. | |
| 776 | 0 | 8 |
_iPrint version: _aDeBrue, Anne N. _tAngiotensin Converting Enzyme Inhibitors _dNew York : Nova Science Publishers, Incorporated,c2009 _z9781606926192 |
| 797 | 2 | _aProQuest (Firm) | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3018321 _zClick to View |
| 999 |
_c59572 _d59572 |
||